R54
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: -decreased muscle mass (DEXA measurement) and function (Handgrip measurement) - increased fat mass > 25% as measured by BIA - No subjective symptoms during exercise - Stable weight and eating behavior - No previous regular physical activity > 60min / week - No contraindications against physical stress correspondending guidelines of ACSM. - No contraindications aaginst additional nutritional or ergogenic supplements
Exclusion criteria
Exclusion criteria: -contraindications regarding sports activities according to the criteriae of the ACSM, 2009 -Diagnosis of cancer within the last 5 years -Allergy/aversion against animal protein -Inability to perform a strenght training -Arterial hypertension (RRsyst > 200 mmHg und/oder RRdiast > 105 mmHg) under resting conditions -Insulin dependant Diabetes mellitus type II -Liver oder kidnes disease with a non-permission to ingest higher concentraions of protein
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in muscle mass after the 3-month training period and supplementation of collagen peptides compared to placebo supplementation verified by DEXA measurement | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are improving arm and leg strength, changes in fat mass and changes in the metabolic risk profile (waist circumference, triglycerides, HDL / LDL cholesterol, blood pressure) after the 3-month training period. Additionally it is examined to which extent the effects are influenced by the oral administration of whey protein and in which extent they draw a distinction between taking whey protein and collagen peptides or placebo. | — |
Countries
Germany
Contacts
Institut für Sport und Sportwissenschaft